サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1596075

POCT（ポイント・オブ・ケア検査）心臓疾患の世界市場、2033年までの機会と戦略

POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
POCT（ポイント・オブ・ケア検査）心臓疾患の世界市場、2033年までの機会と戦略
出版日: 2024年11月21日
発行: The Business Research Company
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場は2018年に13億3,259万米ドルと評価され、2023年まで6.00%以上の複合年間成長率（CAGR）で成長しました。

ポータブルおよびウェアラブルデバイスの採用増加

ポータブルおよびウェアラブルデバイスの採用増加は、実績期間におけるPOCT（ポイント・オブ・ケア検査）心臓疾患市場の成長に貢献しました。ハンドヘルド心電図（ECG）モニタやウェアラブル心拍モニタを含むポータブルおよびウェアラブルPOCTデバイスは、患者やヘルスケアプロバイダが従来の病院環境を超えて心臓検査を実施することを可能にしました。この利便性の向上は、より頻繁な検査と心臓の問題の早期発見を容易にし、それによって市場の成長を促進しました。例えば、米国を拠点とするクリエイティブ・デジタル・エージェンシーであるDigital Silkによると、世界のウェアラブル技術市場は急速に進化しています。2022年までに、世界で接続されるウェアラブル端末の数は11億台を超えると推定されています。注目すべきは、ウェアラブル・テクノロジーを採用した企業の79％が、これらのデバイスが自社の成功に不可欠な役割を果たしていると報告し、76％が全体的なパフォーマンスの向上を実感していることです。さらに、これらの企業の86%はウェアラブルへの投資を増やす予定であり、これは様々な業界でビジネス成果を向上させ、イノベーションを促進する技術の能力に対する強い信念を反映しています。したがって、ポータブル機器やウェアラブル機器の採用が増加していることが、POCT（ポイント・オブ・ケア検査）心臓疾患市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

  • POCT（ポイント・オブ・ケア検査）心臓疾患-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • POCT（ポイント・オブ・ケア検査）心臓疾患市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • デジタルアプリ（ヘルスケアソリューション）
    • 小型検体検査機器
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • 診断検査室
    • その他のエンドユーザー

第7章 主要な市場動向

  • 心臓トロポニンの結果を迅速に提供するポイントオブケア検査の承認増加
  • 心不全の新しいポイントオブケア検査の開始
  • 先進的なポイントオブケア検査機器が健康診断に革命をもたらす
  • 市場での地位を強化するための合併と買収

第8章 POCT（ポイント・オブ・ケア検査）心臓疾患市場- マクロ経済シナリオ

  • COVID-19の影響： POCT（ポイント・オブ・ケア検査）心臓疾患市場
  • ウクライナ戦争の影響： POCT（ポイント・オブ・ケア検査）心臓疾患市場
  • 高インフレの影響： POCT（ポイント・オブ・ケア検査）心臓疾患市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028
  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第10章 POCT（ポイント・オブ・ケア検査）心臓疾患市場：地域・国別分析

  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 POCT（ポイント・オブ・ケア検査）心臓疾患の競合情勢と企業プロファイル

  • Wondfo Biotech Co. Ltd.
  • Siemens Healthineers AG
  • Business Strategy
  • QuidelOrtho Corporation
  • F. Hoffman-La Roche Ltd
  • Abbott Laboratories
  • OraSure Technologies Inc.
  • Hologic Inc.
  • Thermo Fisher Scientific Inc.
  • SARSTEDT AG & Co. KG
  • Nova Biomedical Corporation

第19章 デジタルアプリ（ヘルスケアソリューション）の競合情勢と企業プロファイル

  • デジタルアプリ（ヘルスケアソリューション）市場企業プロファイル
  • QuidelOrtho Corporation
  • Withings SA
  • AliveCor Inc.
  • Business Strategy
  • Preventice Solutions Inc. (Boston Scientific)
  • Koninklijke Philips N.V. (Philips Cardiologs)
  • Qardio Inc.
  • HeartFlow Inc.
  • iRhythm Technologies Inc.
  • LumiraDx Ltd.
  • Huma Ltd.

第20章 小型検体検査機器の競合情勢と企業プロファイル

  • 小型検体検査機器市場企業プロファイル
  • Wondfo Biotech Co. Ltd.
  • Company Overview
  • Products And Services
  • Financial Overview
  • Siemens Healthineers AG
  • F. Hoffman-La Roche Ltd
  • QuidelOrtho Corporation
  • OraSure Technologies Inc.
  • Hologic Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Business Strategy
  • SARSTEDT AG & Co. KG
  • Nova Biomedical Corporation

第21章 主要な合併と買収

  • Roche Holding AG Acquired LumiraDx
  • SD Biosensor, Inc And SJL Partners Acquired Meridian Bioscience, Inc
  • Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
  • Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • Roche Holding AG Acquired GenMark Diagnostics

第22章 機会と戦略

  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場2028：新たな機会を提供する国
  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場2028：新たな機会を提供するセグメント
  • 世界のPOCT（ポイント・オブ・ケア検査）心臓疾患市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第23章 POCT（ポイント・オブ・ケア検査）心臓疾患市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人

第24章 付録

目次
Product Code: o&s1386

Point-of-care testing (POCT) for cardiac disease refers to diagnostic tests performed near or at the site of patient care, allowing for rapid results without the need for centralized laboratory testing. These tests are designed to detect and monitor various cardiac conditions, including acute coronary syndromes, heart failure and other cardiovascular disorders.

The POCT (point of care testing) cardiac disease market consists of sales, by entities (organizations, sole traders and partnerships), of POCT (point of care testing) cardiac disease systems, solutions and services that play a critical role in emergency and urgent care settings, where timely decision-making can significantly impact patient outcomes. The primary users of these tests include healthcare professionals such as doctors, nurses and paramedics, who utilize them to quickly assess cardiac biomarkers, such as troponins and natriuretic peptides, to aid in diagnosing heart attacks or monitoring heart function.

The global POCT (point of care testing) cardiac disease market was valued at $1,332.59 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Increasing Adoption Of Portable And Wearable Devices

Increasing adoption of portable and wearable devices contributed to the growth of the POCT (point of care testing) cardiac disease market in the historic period. Portable and wearable POCT devices, including handheld electrocardiogram (ECG) monitors and wearable heart rate monitors, enabled patients and healthcare providers to perform cardiac tests beyond traditional hospital environments. This increased convenience facilitated more frequent testing and earlier detection of cardiac issues, thereby driving market growth. For instance, according to Digital Silk, a US-based creative digital agency, the global wearable technology market is rapidly evolving. By 2022, the number of connected wearable devices worldwide was estimated to exceed 1.1 billion. Notably, 79% of companies that have adopted wearable technology reported that these devices play a vital role in their success, while 76% saw improvements in overall performance. Furthermore, 86% of these companies plan to increase their investment in wearables, reflecting a strong belief in the technology's ability to enhance business outcomes and drive innovation across various industries. Therefore, the increasing adoption of portable and wearable devices drove the growth of the POCT (point of care testing) cardiac disease market.

Launch Of New Point-Of-Care Tests For Heart Failure

Companies operating in POCT (point of care testing) cardiac disease are launching new point-of-care tests for heart failure which ensures that the test meets the needs of a substantial patient demographic and helps allocate resources effectively to those who need them most. For instance, in April 2024, F. Hoffmann-La Roche AG, a global healthcare leader based in Switzerland, introduced a new POC test for heart failure in India, specifically tailored for patients with diabetes. The NT-proBNP test is designed to support early screening for cardiovascular conditions, including heart failure, in individuals with type 2 diabetes. This test operates on the Cobas h 232 system, which enables rapid testing and delivers immediate results in clinical environments. This advancement is pivotal in identifying patients at risk of heart failure earlier, thereby allowing for timely intervention and improved patient care.

The global POCT (point of care testing) cardiac disease market is fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 6.37% of the total market in 2023.

POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global POCT (point of care testing) cardiac disease market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for POCT (point of care testing) cardiac disease? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POCT (point of care testing) cardiac disease market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider POCT (point of care testing) cardiac disease market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the POCT (point of care testing) cardiac disease market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market..
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for POCT (point of care testing) cardiac disease providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Digital Apps (Healthcare Solutions); Small Specimen Devices
  • 2) By End User: Hospitals; Diagnostic Laboratories; Other End Users
  • Companies Mentioned: Wondfo Biotech Co. Ltd.; Siemens Healthineers AG; QuidelOrtho Corporation; F. Hoffmann-La Roche Ltd.; Abbott Laboratories
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia; Egypt
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POCT (point of care testing) cardiac disease indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 POCT (Point of Care Testing) Cardiac Disease - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 POCT (Point of Care Testing) Cardiac Disease Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Digital Apps (Healthcare Solutions)
    • 6.4.2 Small Specimen Devices
  • 6.5 Market Segmentation By End-User
    • 6.5.1 Hospitals
    • 6.5.2 Diagnostic Laboratories
    • 6.5.3 Other End-Users

7 Major Market Trends

  • 7.1 Increase In Approvals Of Point-Of-Care Test That Deliver Fast Cardiac Troponin Results
  • 7.2 Launch Of New Point-Of-Care Tests For Heart Failure
  • 7.3 Advanced Point-Of-Care Testing Devices Revolutionize Health Diagnostics
  • 7.4 Merger And Acquisitions To Strengthen Market Position

8 POCT (Point of Care Testing) Cardiac Disease Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The POCT (Point of Care Testing) Cardiac Disease Market
  • 8.2 Impact Of The War In Ukraine On The POCT (Point of Care Testing) Cardiac Disease Market
  • 8.3 Impact Of High Inflation On The POCT (Point of Care Testing) Cardiac Disease Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028
  • 9.4 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 9.5 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

10 POCT (Point of Care Testing) Cardiac Disease Market, Regional and Country Analysis

  • 10.1 Global POCT (Point of Care Testing) Cardiac Disease Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global POCT (Point of Care Testing) Cardiac Disease Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
    • 11.1.1 Market Overview
    • 11.1.2 Region Information
    • 11.1.3 Market Information
    • 11.1.4 Background Information
    • 11.1.5 Government Initiatives
    • 11.1.6 Regulations
    • 11.1.7 Regulatory Bodies
    • 11.1.8 Major Associations
    • 11.1.9 Taxes Levied
    • 11.1.10 Corporate Tax Structure
    • 11.1.11 Investments
    • 11.1.12 Major Companies
  • 11.2 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.3 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.4 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
  • 11.5 China Market
  • 11.6 Summary
    • 11.6.1 Market Overview
    • 11.6.2 Country Information
    • 11.6.3 Market Information
    • 11.6.4 Background Information
    • 11.6.5 Government Initiatives
    • 11.6.6 Regulations
    • 11.6.7 Regulatory Bodies
    • 11.6.8 Major Associations
    • 11.6.9 Taxes Levied
    • 11.6.10 Corporate Tax Structure
    • 11.6.11 Investments
    • 11.6.12 Major Companies
  • 11.7 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.8 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.9 India Market
  • 11.10 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.11 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.12 Japan Market
  • 11.13 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.14 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.15 Australia Market
  • 11.16 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.17 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.18 Indonesia Market
  • 11.19 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.20 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.21 South Korea Market
  • 11.22 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.23 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market: Country Analysis
  • 12.5 UK Market
  • 12.6 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.7 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.8 Germany Market
  • 12.9 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 France Market
  • 12.12 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 Italy Market
  • 12.15 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Spain Market
  • 12.18 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
  • 13.5 Russia Market
  • 13.6 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.7 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 North America Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 North America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
  • 14.5 USA Market
  • 14.6 Summary
    • 14.6.1 Market Overview
    • 14.6.2 Country Information
    • 14.6.3 Market Information
    • 14.6.4 Background Information
    • 14.6.5 Government Initiatives
    • 14.6.6 Regulations
    • 14.6.7 Regulatory Bodies
    • 14.6.8 Major Associations
    • 14.6.9 Taxes Levied
    • 14.6.10 Corporate Tax Structure
    • 14.6.11 Investments
    • 14.6.12 Major Companies
  • 14.7 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Canada Market
  • 14.10 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.11 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 South America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 South America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
  • 15.5 Brazil Market
  • 15.6 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.7 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Egypt Market
  • 17.5 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.6 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Competitive Landscape and Company Profiles

  • 18.1 Wondfo Biotech Co. Ltd.
    • 18.1.1 Company Overview
    • 18.1.2 Products And Services
    • 18.1.3 Financial Overview
  • 18.2 Siemens Healthineers AG
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 QuidelOrtho Corporation
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 F. Hoffman-La Roche Ltd
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Abbott Laboratories
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Financial Overview
  • 18.6 OraSure Technologies Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Financial Overview
  • 18.7 Hologic Inc.
    • 18.7.1 Company Overview
    • 18.7.2 Products And Services
    • 18.7.3 Financial Overview
  • 18.8 Thermo Fisher Scientific Inc.
    • 18.8.1 Company Overview
    • 18.8.2 Products And Services
    • 18.8.3 Business Strategy
    • 18.8.4 Financial Overview
  • 18.9 SARSTEDT AG & Co. KG
    • 18.9.1 Company Overview
    • 18.9.2 Products And Services
    • 18.9.3 Financial Overview
  • 18.10 Nova Biomedical Corporation
    • 18.10.1 Company Overview
    • 18.10.2 Products And Services
    • 18.10.3 Financial Overview

19 Digital App (Healthcare Solution) Competitive Landscape and Company Profiles

  • 19.1 Digital App (Healthcare Solution) Market Company Profiles
  • 19.2 QuidelOrtho Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Financial Overview
  • 19.3 Withings SA
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Financial Overview
  • 19.4 AliveCor Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Preventice Solutions Inc. (Boston Scientific)
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial Overview
  • 19.6 Koninklijke Philips N.V. (Philips Cardiologs)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview
  • 19.7 Qardio Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
    • 19.7.3 Financial Overview
  • 19.8 HeartFlow Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
    • 19.8.3 Business Strategy
    • 19.8.4 Financial Overview
  • 19.9 iRhythm Technologies Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
    • 19.9.3 Financial Overview
  • 19.10 LumiraDx Ltd.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
    • 19.10.3 Financial Overview
  • 19.11 Huma Ltd.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
    • 19.11.3 Business Strategy
    • 19.11.4 Financial Overview

20 Small Specimen Devices Competitive Landscape and Company Profiles

  • 20.1 Small Specimen Devices Market Company Profiles
  • 20.2 Wondfo Biotech Co. Ltd.
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
    • 20.2.3 Financial Overview
  • 20.3 Siemens Healthineers AG
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
    • 20.3.3 Financial Overview
  • 20.4 F. Hoffman-La Roche Ltd
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
    • 20.4.3 Financial Overview
  • 20.5 QuidelOrtho Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
    • 20.5.3 Financial Overview
  • 20.6 OraSure Technologies Inc.
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
    • 20.6.3 Financial Overview
  • 20.7 Hologic Inc.
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
    • 20.7.3 Financial Overview
  • 20.8 Abbott Laboratories
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
    • 20.8.3 Financial Overview
  • 20.9 Thermo Fisher Scientific Inc.
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
    • 20.9.3 Business Strategy
    • 20.9.4 Financial Overview
  • 20.10 SARSTEDT AG & Co. KG
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
    • 20.10.3 Financial Overview
  • 20.11 Nova Biomedical Corporation
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
    • 20.11.3 Financial Overview

21 Key Mergers And Acquisitions

  • 21.1 Roche Holding AG Acquired LumiraDx
  • 21.2 SD Biosensor, Inc And SJL Partners Acquired Meridian Bioscience, Inc
  • 21.3 Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
  • 21.4 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • 21.5 Roche Holding AG Acquired GenMark Diagnostics

22 Opportunities And Strategies

  • 22.1 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Countries Offering Most New Opportunities
  • 22.2 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Segments Offering Most New Opportunities
  • 22.3 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Growth Strategies
    • 22.3.1 Market Trend Based Strategies
    • 22.3.2 Competitor Strategies

23 POCT (Point of Care Testing) Cardiac Disease Market, Conclusions And Recommendations

  • 23.1 Conclusions
  • 23.2 Recommendations
    • 23.2.1 Product
    • 23.2.2 Place
    • 23.2.3 Price
    • 23.2.4 Promotion
    • 23.2.5 People

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer